Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-FR Version v8-FR
Language French French
Date Updated 2020-09-21 2020-08-31
Drug Identification Number 02172739 02172739
Brand name OMNIPAQUE 240 OMNIPAQUE 240
Common or Proper name IOHEXOL INJECTION USP IOHEXOL INJECTION USP
Company Name GE HEALTHCARE CANADA INC GE HEALTHCARE CANADA INC
Ingredients IOHEXOL IOHEXOL
Strength(s) 518MG 518MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBARACHNOIDAL INTRAVASCULAR SUBARACHNOIDAL INTRAVASCULAR SUBARACHNOIDAL INTRAVASCULAR SUBARACHNOIDAL INTRAVASCULAR
Packaging size 20 mL 20 mL
ATC code V08AB V08AB
ATC description X-RAY CONTRAST MEDIA, IODINATED X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-09-15 2020-09-15
Actual start date 2020-09-16
Estimated end date 2020-09-25 2020-09-15
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments
Health Canada comments